22 insiders reported 286 Form 4 transactions for VERTEX PHARMACEUTICALS INC / MA (VRTX) over the past 18 months (most recent 2026-07-07). Recent activity: Tatsis Ourania (EVP, Chief Reg. & Quality Off.) Sell 1,500 shares, McKechnie Duncan (EVP, Chief Commercial Officer) Sell 1,541 shares, Liu Joy (EVP and Chief Legal Officer) Sell 828 shares, Bozic Carmen (EVP and CMO) Sell 596 shares, Bozic Carmen (EVP and CMO) Sell 1,020 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | 1,500 | $787,485 |
| 2026-07-07 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 1,541 | $799,779 |
| 2026-07-06 | Liu Joy | EVP and Chief Legal Officer | Sell | 828 | $416,244 |
| 2026-06-30 | Bozic Carmen | EVP and CMO | Sell | 596 | $287,570 |
| 2026-06-23 | Bozic Carmen | EVP and CMO | Sell | 1,020 | $471,413 |
| 2026-06-17 | Bozic Carmen | EVP and CMO | Sell | 4,062 | $1.8M |
| 2026-06-09 | Bozic Carmen | EVP and CMO | Sell | 1,745 | $785,250 |
| 2026-06-03 | Liu Joy | EVP and Chief Legal Officer | Sell | 828 | $364,245 |
| 2026-06-02 | Bozic Carmen | EVP and CMO | Sell | 1,974 | $888,300 |
| 2026-05-19 | Bozic Carmen | EVP and CMO | Sell | 1,354 | $613,971 |
| 2026-05-19 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | 33 | $14,964 |
| 2026-05-14 | Bozic Carmen | EVP and CMO | Sell | 6,988 | $3.1M |
| 2026-04-03 | Liu Joy | EVP and Chief Legal Officer | Sell | 978 | $439,288 |
| 2026-03-31 | Bozic Carmen | EVP and CMO | Sell | 2,329 | $1.1M |
| 2026-03-17 | Bozic Carmen | EVP and CMO | Sell | 2,329 | $1.1M |
| 2026-03-13 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 2,633 | $1.3M |
| 2026-03-06 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | 2,437 | $1.2M |
| 2026-03-04 | Liu Joy | EVP and Chief Legal Officer | Sell | 892 | $442,396 |
| 2026-03-03 | Kewalramani Reshma | CEO & President | Sell | 400 | $191,900 |
| 2026-03-03 | Kewalramani Reshma | CEO & President | Sell | 120 | $57,780 |
| 2026-03-03 | Kewalramani Reshma | CEO & President | Sell | 240 | $115,882 |
| 2026-03-03 | Kewalramani Reshma | CEO & President | Sell | 2,510 | $1.2M |
| 2026-03-03 | Kewalramani Reshma | CEO & President | Sell | 3,278 | $1.6M |
| 2026-03-03 | Kewalramani Reshma | CEO & President | Sell | 460 | $225,087 |
| 2026-03-03 | Kewalramani Reshma | CEO & President | Sell | 2,725 | $1.3M |
Source: SEC Form 4 filings · as of 2026-07-07